Hôpital Haut Leveque, Centre Francois Magendie

Pessac 33604

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Human Immunodeficiency Virus, Myelodysplastic Syndrome

Studies at this site

• A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed